MX2009006313A - Antagonistas v3 para el tratamiento o prevencion de dolor cronico. - Google Patents
Antagonistas v3 para el tratamiento o prevencion de dolor cronico.Info
- Publication number
- MX2009006313A MX2009006313A MX2009006313A MX2009006313A MX2009006313A MX 2009006313 A MX2009006313 A MX 2009006313A MX 2009006313 A MX2009006313 A MX 2009006313A MX 2009006313 A MX2009006313 A MX 2009006313A MX 2009006313 A MX2009006313 A MX 2009006313A
- Authority
- MX
- Mexico
- Prior art keywords
- treatment
- antagonists
- prevention
- chronic pain
- pain
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Pain & Pain Management (AREA)
- Engineering & Computer Science (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
La presente invención se relaciona con un antagonista V3 para su uso en el tratamiento de dolor crónico, en particular dolor neuropático.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP06126003 | 2006-12-13 | ||
PCT/EP2007/063913 WO2008071779A1 (en) | 2006-12-13 | 2007-12-13 | V3 antagonists for the treatment or prevention of chronic pain |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2009006313A true MX2009006313A (es) | 2009-06-23 |
Family
ID=37654964
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2009006313A MX2009006313A (es) | 2006-12-13 | 2007-12-13 | Antagonistas v3 para el tratamiento o prevencion de dolor cronico. |
Country Status (6)
Country | Link |
---|---|
US (1) | US20100179176A1 (es) |
EP (1) | EP2101746B1 (es) |
JP (1) | JP5268935B2 (es) |
CA (1) | CA2671891C (es) |
MX (1) | MX2009006313A (es) |
WO (1) | WO2008071779A1 (es) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9617226B2 (en) | 2014-09-05 | 2017-04-11 | AbbVie Deutschland GmbH & Co. KG | Fused heterocyclic or carbocyclic compounds carrying a substituted cycloaliphatic radical and use thereof for treating vasopressin-related diseases |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2804114B1 (fr) | 2000-01-25 | 2002-03-08 | Sanofi Synthelabo | Nouveaux derives de 1,3-dihydro-2h-indol-2-one, un procede pour leur preparation et les compositions pharmaceutiques en contenant |
US20040087642A1 (en) * | 2002-10-24 | 2004-05-06 | Zeldis Jerome B. | Methods of using and compositions comprising a JNK inhibitor for the treatment, prevention, management and/or modification of pain |
US7807696B2 (en) * | 2003-10-07 | 2010-10-05 | The Feinstein Institute For Medical Research | Isoxazole and isothiazole compounds useful in the treatment of inflammation |
EP1842555A4 (en) * | 2004-12-27 | 2009-08-19 | Univ Kyoto | TOLERANCE DEVELOPMENT INHIBITOR FOR A NARCOTIC ANALGESIC AGENT |
TW200643015A (en) * | 2005-03-11 | 2006-12-16 | Akzo Nobel Nv | 2-(4-oxo-4H-quinazolin-3-yl)acetamide derivatives |
-
2007
- 2007-12-13 US US12/518,940 patent/US20100179176A1/en not_active Abandoned
- 2007-12-13 CA CA2671891A patent/CA2671891C/en active Active
- 2007-12-13 WO PCT/EP2007/063913 patent/WO2008071779A1/en active Application Filing
- 2007-12-13 JP JP2009540781A patent/JP5268935B2/ja active Active
- 2007-12-13 EP EP07857560.2A patent/EP2101746B1/en active Active
- 2007-12-13 MX MX2009006313A patent/MX2009006313A/es active IP Right Grant
Also Published As
Publication number | Publication date |
---|---|
US20100179176A1 (en) | 2010-07-15 |
WO2008071779A1 (en) | 2008-06-19 |
EP2101746A1 (en) | 2009-09-23 |
CA2671891A1 (en) | 2008-06-19 |
EP2101746B1 (en) | 2013-12-11 |
JP5268935B2 (ja) | 2013-08-21 |
JP2010513249A (ja) | 2010-04-30 |
CA2671891C (en) | 2015-05-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MY160456A (en) | Benzodiazepine bromodomain inhibitor | |
WO2011005942A3 (en) | Oligonucleotide-based compounds as inhibitors of toll-like receptors | |
AP2258A (en) | Tamper resistant dosage forms. | |
EP2045251A4 (en) | COMPOUNDS WHICH CAN INCLUDE THE UBC13-UEV INTERACTIONS, PHARMACEUTICAL COMPOSITIONS AND THERAPEUTIC APPLICATIONS | |
EP1986652A4 (en) | AMINOETETRAHYDROPYRANES AS DIPEPTIDYLPEPTIDASE IV INHIBITORS FOR THE TREATMENT OR PREVENTION OF DIABETES | |
EP1978804A4 (en) | AMINOCYCLOHEXANES USEFUL AS INHIBITORS OF DIPEPTIDYL PEPTIDASE-IV FOR TREATING OR PREVENTING DIABETES | |
EP2019677A4 (en) | AMINOETETRAHYDROPYRANES AS DIPEPTIDYLPEPTIDASE IV INHIBITORS FOR THE TREATMENT OR PREVENTION OF DIABETES | |
SG163564A1 (en) | Kinin antagonists for treating bladder dysfunction | |
MY150602A (en) | Subtituted-quinoxaline-type piperidine compounds and the uses thereof | |
MY144857A (en) | Phamaceutical composition comprising amlodipine and losartan | |
WO2008095086A3 (en) | Topiramate plus naltrexone for the treatment of addictive disorders | |
MY153948A (en) | Substituted-quinoxaline-type bridged-piperidine compounds and the uses thereof | |
GB2454620A (en) | Solid dosage form of olmesartan medoxomil and amlodipine | |
GB0600692D0 (en) | Well treatment | |
ZA200807488B (en) | Aminotetrahydropyrans as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes | |
MY150600A (en) | Use of opioid antagonists for treating urinary retention | |
TW200700071A (en) | Novel use | |
SG2014010581A (en) | Attenuated pestivirus | |
MX2009011346A (es) | Tapentadol para tratamiento de dolor con artritis. | |
GB2482817A (en) | Novel use | |
MX2010007669A (es) | Metodos para inhibir la angiogenesis utilizando antagonistas de egfl8. | |
SI2001456T1 (sl) | Uporaba zmesi, ki vsebuje antagonist na opioidnem kapa receptorju za zdravljenje disocialnih bolezni | |
JO2730B1 (en) | Medications for the treatment of endometriosis | |
UA96476C2 (ru) | Фармацевтические композиции, которые содержат ирбесартан | |
WO2007131041A3 (en) | The use of a glucocorticoid receptor ii antagonist to treat depression in patients taking il-2 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
GB | Transfer or rights | ||
FG | Grant or registration | ||
GB | Transfer or rights |